.jpg)
.jpg)
Somewhere in the correspondence files of East Kent Hospitals University Foundation Trust sits a draft investigation report that few outside the organisation will ever read in full, yet its conclusion has already reshaped the trust's leadership. Annette Doherty resigned as chair after the inquiry found she had exceeded her authority in suspending the trust's chief executive. Her successor, announced this week, is Hilary Thomas, a clinical oncologist who takes up the post on 2 November after Olu Olasode has held the chair on an interim basis since April.
On its surface this is a routine personnel change, the kind of appointment that circulates in trade press and disappears within days. Underneath it sits a more uncomfortable question that has been building across NHS governance for several years: what happens when the people appointed to hold executive teams to account overstep the very authority meant to keep them in check.
Trust chairs occupy an unusual position in the NHS architecture. They are non-executive, often drawn from outside healthcare, and tasked with providing scrutiny rather than management. Their power over a chief executive is real but bounded, exercised through formal processes rather than unilateral action. When a chair suspends a chief executive without following those processes, the damage is not confined to the individual relationship. It exposes how thin the guardrails around board conduct can be, and how much depends on the judgement of people who are rarely subject to the same performance management as the executives they oversee.
East Kent has spent much of the past decade under intense scrutiny, most visibly through the Kirkup review into maternity failings that named the trust specifically. A board unable to manage its own internal conduct arrives at a particularly poor moment for an organisation still working to demonstrate it has absorbed the lessons of that period. Governance failures compound reputational ones. A trust trying to convince patients, staff and regulators that its culture has changed cannot easily do so while its own leadership dispute is being adjudicated by an outside investigation.
The choice of a practising oncologist to fill the vacancy is not incidental. Clinical chairs remain unusual in NHS trusts, where the role has traditionally gone to figures with backgrounds in business, local government or the civil service. Bringing in someone with direct experience of clinical practice suggests an attempt to rebuild credibility from the ground rather than the boardroom outward, on the assumption that staff and patients may trust a leader who has treated patients more readily than one whose authority rests solely on governance credentials. Whether that assumption holds depends heavily on how the new chair uses her position, and whether clinical standing translates into the kind of institutional discipline that was absent under her predecessor.
There is a wider pattern here that NHS England and the Department of Health and Social Care have been reluctant to address directly. Trust boards operate with considerable latitude, and the mechanisms for holding chairs accountable when they misuse that latitude are slower and less transparent than those governing chief executives. A chief executive under formal suspension faces immediate public and regulatory attention. A chair who mishandles that suspension can resign quietly, as Doherty did, with the underlying investigation surfacing only through specialist reporting rather than ministerial statement. This asymmetry matters as the government pushes ahead with further devolution of accountability to integrated care systems and local leadership, a shift that presumes boards are equipped to self-regulate.
For NHS leaders watching from other trusts, the lesson is not really about East Kent specifically. It is about the durability of governance codes when tested by personal conflict at the top of an organisation, and about how little visibility exists into these disputes until they have already caused damage. Appointing a well-regarded clinician to chair the board may stabilise East Kent in the short term. It does little to answer the structural question the episode has raised, which is who is watching the people meant to be doing the watching.